1500 – 1055 West Georgia Street
Vancouver, BC V6E 4N7
Full Time Employees:
|Mr. Ian McDonald||Co-Founder, CEO, Pres & Director||N/A||N/A||1988|
|Mr. Ryan E. S. K. Cheung B.Com., CA, CPA||Chief Financial Officer||66.85k||N/A||1978|
|Dr. Revati Shreeniwas FCCP, M.D., Ph.D.||Chief Medical Officer||188.47k||N/A||1961|
|Dr. Emer Leahy M.B.A., Ph.D.||Consultant||N/A||N/A||1967|
|Dr. Jan Torleif Pedersen M.Sc., Ph.D.||Interim Chief Science Officer & Director||N/A||N/A||N/A|
|Dr. Gideon Shapiro Ph.D.||VP of Discovery||N/A||N/A||N/A|
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
Bright Minds Biosciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.